An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, in preliminary provisions, further providing for definitions; in medical marijuana controls, further providing for electronic tracking and for laboratory; and, in Medical Marijuana Advisory Board, further providing for advisory board.

HB 2208 amends Pennsylvania's Medical Marijuana Act to update definitions, strengthen laboratory oversight, and improve electronic tracking. The bill clarifies what constitutes an independent laboratory and accreditation body, ensuring they remain free from conflicts of interest with medical marijuana organizations. It also mandates that data within the state's electronic tracking system remain confidential and exempt from public disclosure laws. Additionally, the legislation requires growers and processors to contract with approved independent labs for testing product potency and purity at specific stages of production.